Webinar on 6/21: Big Pharma, the FDA and Breast Cancer: Patients Before Profits

On June 21st we will be turning BCAction’s critical eye on the FDA and its drug approval process.

Register now!

Breast cancer treatments should be both the most effective and the least toxic possible. The standards used by the FDA for the approval of new breast cancer therapies and devices should ensure this outcome. However, pharmaceutical companies, the government and cancer patients don’t share the same interests.

Join this webinar to learn about whom the power players at the FDA are, BCAction’s take on the related conflicts of interests, and the history of the drug approval process.

This entry was posted in BCA Events, BCA News.

One Response to Webinar on 6/21: Big Pharma, the FDA and Breast Cancer: Patients Before Profits

  1. Wonderful submit, very informative. I’m wondering why the opposite experts of this sector do not understand this. You should continue your writing. I am sure, you have a great readers’ base already!|What’s Taking place i’m new to this, I stumbled upon this I have found It positively helpful and it has aided me out loads. I’m hoping to contribute & aid other users like its helped me. Great job.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>